nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—HSP90B1—coronary artery disease	0.544	1	CbGaD
Rifabutin—CYP1A2—Gemfibrozil—coronary artery disease	0.0288	0.137	CbGbCtD
Rifabutin—CYP1A2—Clopidogrel—coronary artery disease	0.025	0.119	CbGbCtD
Rifabutin—CYP3A4—Ticagrelor—coronary artery disease	0.0212	0.101	CbGbCtD
Rifabutin—CYP3A4—Fenofibrate—coronary artery disease	0.0189	0.0896	CbGbCtD
Rifabutin—CYP3A4—Gemfibrozil—coronary artery disease	0.0151	0.0716	CbGbCtD
Rifabutin—CYP3A4—Clopidogrel—coronary artery disease	0.0131	0.0621	CbGbCtD
Rifabutin—CYP1A2—Losartan—coronary artery disease	0.0122	0.0579	CbGbCtD
Rifabutin—CYP3A4—Eplerenone—coronary artery disease	0.0122	0.0577	CbGbCtD
Rifabutin—CYP3A4—Enalapril—coronary artery disease	0.0109	0.0515	CbGbCtD
Rifabutin—CYP3A4—Ezetimibe—coronary artery disease	0.00844	0.04	CbGbCtD
Rifabutin—CYP3A4—Rosuvastatin—coronary artery disease	0.00844	0.04	CbGbCtD
Rifabutin—CYP3A4—Simvastatin—coronary artery disease	0.00785	0.0372	CbGbCtD
Rifabutin—CYP3A4—Lovastatin—coronary artery disease	0.00768	0.0364	CbGbCtD
Rifabutin—CYP3A4—Pravastatin—coronary artery disease	0.00768	0.0364	CbGbCtD
Rifabutin—CYP3A4—Atorvastatin—coronary artery disease	0.007	0.0332	CbGbCtD
Rifabutin—CYP3A4—Losartan—coronary artery disease	0.0064	0.0303	CbGbCtD
Rifabutin—HSP90AA1—endothelium—coronary artery disease	0.00295	0.127	CbGeAlD
Rifabutin—HSP90B1—cardiac ventricle—coronary artery disease	0.00268	0.115	CbGeAlD
Rifabutin—HSP90B1—myocardium—coronary artery disease	0.00252	0.108	CbGeAlD
Rifabutin—HSP90AA1—cardiac ventricle—coronary artery disease	0.00196	0.0841	CbGeAlD
Rifabutin—HSP90AA1—myocardium—coronary artery disease	0.00184	0.0791	CbGeAlD
Rifabutin—HSP90B1—heart—coronary artery disease	0.00176	0.0755	CbGeAlD
Rifabutin—HSP90B1—cardiovascular system—coronary artery disease	0.00166	0.0713	CbGeAlD
Rifabutin—HSP90B1—cardiac atrium—coronary artery disease	0.0015	0.0646	CbGeAlD
Rifabutin—HSP90B1—blood—coronary artery disease	0.00131	0.0564	CbGeAlD
Rifabutin—HSP90AA1—heart—coronary artery disease	0.00128	0.0552	CbGeAlD
Rifabutin—HSP90AA1—cardiovascular system—coronary artery disease	0.00121	0.0521	CbGeAlD
Rifabutin—HSP90AA1—cardiac atrium—coronary artery disease	0.0011	0.0472	CbGeAlD
Rifabutin—HSP90AA1—blood—coronary artery disease	0.000959	0.0412	CbGeAlD
Rifabutin—CYP1A2—blood—coronary artery disease	0.00031	0.0133	CbGeAlD
Rifabutin—CYP3A4—blood—coronary artery disease	0.000224	0.00965	CbGeAlD
Rifabutin—Vomiting—Fenofibrate—coronary artery disease	8.19e-05	0.000701	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Losartan—coronary artery disease	8.19e-05	0.0007	CcSEcCtD
Rifabutin—Hypersensitivity—Valsartan—coronary artery disease	8.19e-05	0.0007	CcSEcCtD
Rifabutin—Convulsion—Ramipril—coronary artery disease	8.18e-05	0.0007	CcSEcCtD
Rifabutin—Body temperature increased—Trandolapril—coronary artery disease	8.17e-05	0.000699	CcSEcCtD
Rifabutin—Abdominal pain—Trandolapril—coronary artery disease	8.17e-05	0.000699	CcSEcCtD
Rifabutin—Body temperature increased—Enalapril—coronary artery disease	8.13e-05	0.000696	CcSEcCtD
Rifabutin—Abdominal pain—Enalapril—coronary artery disease	8.13e-05	0.000696	CcSEcCtD
Rifabutin—Feeling abnormal—Captopril—coronary artery disease	8.13e-05	0.000696	CcSEcCtD
Rifabutin—Insomnia—Losartan—coronary artery disease	8.13e-05	0.000695	CcSEcCtD
Rifabutin—Rash—Fenofibrate—coronary artery disease	8.12e-05	0.000695	CcSEcCtD
Rifabutin—Dermatitis—Fenofibrate—coronary artery disease	8.12e-05	0.000694	CcSEcCtD
Rifabutin—Decreased appetite—Furosemide—coronary artery disease	8.1e-05	0.000693	CcSEcCtD
Rifabutin—Headache—Fenofibrate—coronary artery disease	8.07e-05	0.00069	CcSEcCtD
Rifabutin—Paraesthesia—Losartan—coronary artery disease	8.07e-05	0.00069	CcSEcCtD
Rifabutin—Gastrointestinal pain—Captopril—coronary artery disease	8.07e-05	0.00069	CcSEcCtD
Rifabutin—Vomiting—Clopidogrel—coronary artery disease	8.05e-05	0.000689	CcSEcCtD
Rifabutin—Diarrhoea—Simvastatin—coronary artery disease	8.05e-05	0.000689	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Furosemide—coronary artery disease	8.04e-05	0.000688	CcSEcCtD
Rifabutin—Chest pain—Ramipril—coronary artery disease	8.04e-05	0.000688	CcSEcCtD
Rifabutin—Arthralgia—Ramipril—coronary artery disease	8.04e-05	0.000688	CcSEcCtD
Rifabutin—Myalgia—Ramipril—coronary artery disease	8.04e-05	0.000688	CcSEcCtD
Rifabutin—Abdominal pain—Telmisartan—coronary artery disease	8.02e-05	0.000686	CcSEcCtD
Rifabutin—Body temperature increased—Telmisartan—coronary artery disease	8.02e-05	0.000686	CcSEcCtD
Rifabutin—Dyspnoea—Losartan—coronary artery disease	8.01e-05	0.000685	CcSEcCtD
Rifabutin—Vomiting—Lovastatin—coronary artery disease	8e-05	0.000684	CcSEcCtD
Rifabutin—Rash—Clopidogrel—coronary artery disease	7.99e-05	0.000683	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.98e-05	0.000683	CcSEcCtD
Rifabutin—Dermatitis—Clopidogrel—coronary artery disease	7.98e-05	0.000682	CcSEcCtD
Rifabutin—Asthenia—Valsartan—coronary artery disease	7.97e-05	0.000682	CcSEcCtD
Rifabutin—Pain—Furosemide—coronary artery disease	7.97e-05	0.000681	CcSEcCtD
Rifabutin—Hypersensitivity—Niacin—coronary artery disease	7.96e-05	0.000681	CcSEcCtD
Rifabutin—Asthenia—Olmesartan—coronary artery disease	7.94e-05	0.000679	CcSEcCtD
Rifabutin—Headache—Clopidogrel—coronary artery disease	7.93e-05	0.000679	CcSEcCtD
Rifabutin—Rash—Lovastatin—coronary artery disease	7.93e-05	0.000678	CcSEcCtD
Rifabutin—Dermatitis—Lovastatin—coronary artery disease	7.93e-05	0.000678	CcSEcCtD
Rifabutin—Anaemia—Lisinopril—coronary artery disease	7.92e-05	0.000677	CcSEcCtD
Rifabutin—Dyspepsia—Losartan—coronary artery disease	7.91e-05	0.000677	CcSEcCtD
Rifabutin—Feeling abnormal—Perindopril—coronary artery disease	7.9e-05	0.000675	CcSEcCtD
Rifabutin—Headache—Lovastatin—coronary artery disease	7.88e-05	0.000674	CcSEcCtD
Rifabutin—Pruritus—Valsartan—coronary artery disease	7.86e-05	0.000672	CcSEcCtD
Rifabutin—Arthralgia—Timolol—coronary artery disease	7.86e-05	0.000672	CcSEcCtD
Rifabutin—Chest pain—Timolol—coronary artery disease	7.86e-05	0.000672	CcSEcCtD
Rifabutin—Myalgia—Timolol—coronary artery disease	7.86e-05	0.000672	CcSEcCtD
Rifabutin—Vomiting—Ezetimibe—coronary artery disease	7.85e-05	0.000671	CcSEcCtD
Rifabutin—Hypersensitivity—Pravastatin—coronary artery disease	7.84e-05	0.00067	CcSEcCtD
Rifabutin—Gastrointestinal pain—Perindopril—coronary artery disease	7.84e-05	0.00067	CcSEcCtD
Rifabutin—Pruritus—Olmesartan—coronary artery disease	7.82e-05	0.000669	CcSEcCtD
Rifabutin—Decreased appetite—Losartan—coronary artery disease	7.81e-05	0.000668	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.81e-05	0.000668	CcSEcCtD
Rifabutin—Abdominal pain—Captopril—coronary artery disease	7.8e-05	0.000667	CcSEcCtD
Rifabutin—Body temperature increased—Captopril—coronary artery disease	7.8e-05	0.000667	CcSEcCtD
Rifabutin—Rash—Ezetimibe—coronary artery disease	7.78e-05	0.000665	CcSEcCtD
Rifabutin—Dermatitis—Ezetimibe—coronary artery disease	7.77e-05	0.000665	CcSEcCtD
Rifabutin—Confusional state—Ramipril—coronary artery disease	7.77e-05	0.000665	CcSEcCtD
Rifabutin—Asthenia—Niacin—coronary artery disease	7.75e-05	0.000663	CcSEcCtD
Rifabutin—Headache—Ezetimibe—coronary artery disease	7.73e-05	0.000661	CcSEcCtD
Rifabutin—Pain—Losartan—coronary artery disease	7.69e-05	0.000657	CcSEcCtD
Rifabutin—Vomiting—Eplerenone—coronary artery disease	7.68e-05	0.000657	CcSEcCtD
Rifabutin—Feeling abnormal—Furosemide—coronary artery disease	7.68e-05	0.000657	CcSEcCtD
Rifabutin—Leukopenia—Lisinopril—coronary artery disease	7.67e-05	0.000656	CcSEcCtD
Rifabutin—Nausea—Fenofibrate—coronary artery disease	7.65e-05	0.000655	CcSEcCtD
Rifabutin—Pruritus—Niacin—coronary artery disease	7.64e-05	0.000654	CcSEcCtD
Rifabutin—Asthenia—Pravastatin—coronary artery disease	7.63e-05	0.000653	CcSEcCtD
Rifabutin—Gastrointestinal pain—Furosemide—coronary artery disease	7.62e-05	0.000651	CcSEcCtD
Rifabutin—Rash—Eplerenone—coronary artery disease	7.62e-05	0.000651	CcSEcCtD
Rifabutin—Hypersensitivity—Trandolapril—coronary artery disease	7.61e-05	0.000651	CcSEcCtD
Rifabutin—Dermatitis—Eplerenone—coronary artery disease	7.61e-05	0.000651	CcSEcCtD
Rifabutin—Diarrhoea—Valsartan—coronary artery disease	7.6e-05	0.00065	CcSEcCtD
Rifabutin—Confusional state—Timolol—coronary artery disease	7.6e-05	0.00065	CcSEcCtD
Rifabutin—Shock—Ramipril—coronary artery disease	7.58e-05	0.000648	CcSEcCtD
Rifabutin—Hypersensitivity—Enalapril—coronary artery disease	7.58e-05	0.000648	CcSEcCtD
Rifabutin—Abdominal pain—Perindopril—coronary artery disease	7.58e-05	0.000648	CcSEcCtD
Rifabutin—Body temperature increased—Perindopril—coronary artery disease	7.58e-05	0.000648	CcSEcCtD
Rifabutin—Diarrhoea—Olmesartan—coronary artery disease	7.57e-05	0.000647	CcSEcCtD
Rifabutin—Headache—Eplerenone—coronary artery disease	7.57e-05	0.000647	CcSEcCtD
Rifabutin—Thrombocytopenia—Ramipril—coronary artery disease	7.55e-05	0.000645	CcSEcCtD
Rifabutin—Pruritus—Pravastatin—coronary artery disease	7.53e-05	0.000644	CcSEcCtD
Rifabutin—Nausea—Clopidogrel—coronary artery disease	7.52e-05	0.000643	CcSEcCtD
Rifabutin—Skin disorder—Ramipril—coronary artery disease	7.49e-05	0.00064	CcSEcCtD
Rifabutin—Vomiting—Simvastatin—coronary artery disease	7.48e-05	0.00064	CcSEcCtD
Rifabutin—Hypersensitivity—Telmisartan—coronary artery disease	7.48e-05	0.00064	CcSEcCtD
Rifabutin—Nausea—Lovastatin—coronary artery disease	7.47e-05	0.000639	CcSEcCtD
Rifabutin—Rash—Simvastatin—coronary artery disease	7.42e-05	0.000635	CcSEcCtD
Rifabutin—Dermatitis—Simvastatin—coronary artery disease	7.41e-05	0.000634	CcSEcCtD
Rifabutin—Asthenia—Trandolapril—coronary artery disease	7.41e-05	0.000634	CcSEcCtD
Rifabutin—Shock—Timolol—coronary artery disease	7.41e-05	0.000634	CcSEcCtD
Rifabutin—Feeling abnormal—Losartan—coronary artery disease	7.41e-05	0.000633	CcSEcCtD
Rifabutin—Diarrhoea—Niacin—coronary artery disease	7.39e-05	0.000632	CcSEcCtD
Rifabutin—Asthenia—Enalapril—coronary artery disease	7.38e-05	0.000631	CcSEcCtD
Rifabutin—Headache—Simvastatin—coronary artery disease	7.37e-05	0.000631	CcSEcCtD
Rifabutin—Abdominal pain—Furosemide—coronary artery disease	7.36e-05	0.00063	CcSEcCtD
Rifabutin—Body temperature increased—Furosemide—coronary artery disease	7.36e-05	0.00063	CcSEcCtD
Rifabutin—Gastrointestinal pain—Losartan—coronary artery disease	7.35e-05	0.000629	CcSEcCtD
Rifabutin—Anorexia—Ramipril—coronary artery disease	7.35e-05	0.000628	CcSEcCtD
Rifabutin—Nausea—Ezetimibe—coronary artery disease	7.33e-05	0.000627	CcSEcCtD
Rifabutin—Skin disorder—Timolol—coronary artery disease	7.32e-05	0.000626	CcSEcCtD
Rifabutin—Pruritus—Trandolapril—coronary artery disease	7.31e-05	0.000625	CcSEcCtD
Rifabutin—Chest pain—Lisinopril—coronary artery disease	7.29e-05	0.000624	CcSEcCtD
Rifabutin—Arthralgia—Lisinopril—coronary artery disease	7.29e-05	0.000624	CcSEcCtD
Rifabutin—Myalgia—Lisinopril—coronary artery disease	7.29e-05	0.000624	CcSEcCtD
Rifabutin—Asthenia—Telmisartan—coronary artery disease	7.28e-05	0.000623	CcSEcCtD
Rifabutin—Pruritus—Enalapril—coronary artery disease	7.28e-05	0.000623	CcSEcCtD
Rifabutin—Diarrhoea—Pravastatin—coronary artery disease	7.28e-05	0.000623	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.24e-05	0.000619	CcSEcCtD
Rifabutin—Anorexia—Timolol—coronary artery disease	7.18e-05	0.000614	CcSEcCtD
Rifabutin—Pruritus—Telmisartan—coronary artery disease	7.18e-05	0.000614	CcSEcCtD
Rifabutin—Nausea—Eplerenone—coronary artery disease	7.17e-05	0.000614	CcSEcCtD
Rifabutin—Body temperature increased—Losartan—coronary artery disease	7.11e-05	0.000608	CcSEcCtD
Rifabutin—Abdominal pain—Losartan—coronary artery disease	7.11e-05	0.000608	CcSEcCtD
Rifabutin—Asthenia—Captopril—coronary artery disease	7.08e-05	0.000606	CcSEcCtD
Rifabutin—Diarrhoea—Trandolapril—coronary artery disease	7.07e-05	0.000605	CcSEcCtD
Rifabutin—Vomiting—Valsartan—coronary artery disease	7.07e-05	0.000604	CcSEcCtD
Rifabutin—Confusional state—Lisinopril—coronary artery disease	7.05e-05	0.000603	CcSEcCtD
Rifabutin—Diarrhoea—Enalapril—coronary artery disease	7.04e-05	0.000602	CcSEcCtD
Rifabutin—Vomiting—Olmesartan—coronary artery disease	7.03e-05	0.000601	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Ramipril—coronary artery disease	7.02e-05	0.000601	CcSEcCtD
Rifabutin—Rash—Valsartan—coronary artery disease	7.01e-05	0.000599	CcSEcCtD
Rifabutin—Dermatitis—Valsartan—coronary artery disease	7e-05	0.000599	CcSEcCtD
Rifabutin—Nausea—Simvastatin—coronary artery disease	6.99e-05	0.000598	CcSEcCtD
Rifabutin—Pruritus—Captopril—coronary artery disease	6.98e-05	0.000597	CcSEcCtD
Rifabutin—Rash—Olmesartan—coronary artery disease	6.97e-05	0.000596	CcSEcCtD
Rifabutin—Insomnia—Ramipril—coronary artery disease	6.97e-05	0.000596	CcSEcCtD
Rifabutin—Dermatitis—Olmesartan—coronary artery disease	6.97e-05	0.000596	CcSEcCtD
Rifabutin—Headache—Valsartan—coronary artery disease	6.96e-05	0.000595	CcSEcCtD
Rifabutin—Diarrhoea—Telmisartan—coronary artery disease	6.94e-05	0.000594	CcSEcCtD
Rifabutin—Headache—Olmesartan—coronary artery disease	6.93e-05	0.000593	CcSEcCtD
Rifabutin—Paraesthesia—Ramipril—coronary artery disease	6.92e-05	0.000592	CcSEcCtD
Rifabutin—Shock—Lisinopril—coronary artery disease	6.88e-05	0.000588	CcSEcCtD
Rifabutin—Asthenia—Perindopril—coronary artery disease	6.88e-05	0.000588	CcSEcCtD
Rifabutin—Dyspnoea—Ramipril—coronary artery disease	6.87e-05	0.000588	CcSEcCtD
Rifabutin—Vomiting—Niacin—coronary artery disease	6.87e-05	0.000588	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Timolol—coronary artery disease	6.86e-05	0.000587	CcSEcCtD
Rifabutin—Hypersensitivity—Furosemide—coronary artery disease	6.86e-05	0.000587	CcSEcCtD
Rifabutin—Thrombocytopenia—Lisinopril—coronary artery disease	6.84e-05	0.000585	CcSEcCtD
Rifabutin—Insomnia—Timolol—coronary artery disease	6.81e-05	0.000583	CcSEcCtD
Rifabutin—Rash—Niacin—coronary artery disease	6.81e-05	0.000583	CcSEcCtD
Rifabutin—Dermatitis—Niacin—coronary artery disease	6.81e-05	0.000582	CcSEcCtD
Rifabutin—Skin disorder—Lisinopril—coronary artery disease	6.79e-05	0.000581	CcSEcCtD
Rifabutin—Dyspepsia—Ramipril—coronary artery disease	6.78e-05	0.00058	CcSEcCtD
Rifabutin—Pruritus—Perindopril—coronary artery disease	6.78e-05	0.00058	CcSEcCtD
Rifabutin—Headache—Niacin—coronary artery disease	6.77e-05	0.000579	CcSEcCtD
Rifabutin—Paraesthesia—Timolol—coronary artery disease	6.77e-05	0.000579	CcSEcCtD
Rifabutin—Vomiting—Pravastatin—coronary artery disease	6.76e-05	0.000579	CcSEcCtD
Rifabutin—Diarrhoea—Captopril—coronary artery disease	6.75e-05	0.000578	CcSEcCtD
Rifabutin—Dyspnoea—Timolol—coronary artery disease	6.72e-05	0.000574	CcSEcCtD
Rifabutin—Rash—Pravastatin—coronary artery disease	6.71e-05	0.000574	CcSEcCtD
Rifabutin—Dermatitis—Pravastatin—coronary artery disease	6.7e-05	0.000573	CcSEcCtD
Rifabutin—Decreased appetite—Ramipril—coronary artery disease	6.7e-05	0.000573	CcSEcCtD
Rifabutin—Asthenia—Furosemide—coronary artery disease	6.68e-05	0.000572	CcSEcCtD
Rifabutin—Headache—Pravastatin—coronary artery disease	6.67e-05	0.00057	CcSEcCtD
Rifabutin—Anorexia—Lisinopril—coronary artery disease	6.66e-05	0.00057	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Ramipril—coronary artery disease	6.65e-05	0.000569	CcSEcCtD
Rifabutin—Dyspepsia—Timolol—coronary artery disease	6.63e-05	0.000567	CcSEcCtD
Rifabutin—Hypersensitivity—Losartan—coronary artery disease	6.62e-05	0.000566	CcSEcCtD
Rifabutin—Nausea—Valsartan—coronary artery disease	6.6e-05	0.000565	CcSEcCtD
Rifabutin—Pruritus—Furosemide—coronary artery disease	6.59e-05	0.000564	CcSEcCtD
Rifabutin—Nausea—Olmesartan—coronary artery disease	6.57e-05	0.000562	CcSEcCtD
Rifabutin—Vomiting—Trandolapril—coronary artery disease	6.57e-05	0.000562	CcSEcCtD
Rifabutin—Diarrhoea—Perindopril—coronary artery disease	6.56e-05	0.000561	CcSEcCtD
Rifabutin—Decreased appetite—Timolol—coronary artery disease	6.55e-05	0.00056	CcSEcCtD
Rifabutin—Vomiting—Enalapril—coronary artery disease	6.54e-05	0.00056	CcSEcCtD
Rifabutin—Rash—Trandolapril—coronary artery disease	6.51e-05	0.000557	CcSEcCtD
Rifabutin—Dermatitis—Trandolapril—coronary artery disease	6.51e-05	0.000557	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Timolol—coronary artery disease	6.5e-05	0.000556	CcSEcCtD
Rifabutin—Rash—Enalapril—coronary artery disease	6.49e-05	0.000555	CcSEcCtD
Rifabutin—Dermatitis—Enalapril—coronary artery disease	6.48e-05	0.000554	CcSEcCtD
Rifabutin—Headache—Trandolapril—coronary artery disease	6.47e-05	0.000554	CcSEcCtD
Rifabutin—Vomiting—Telmisartan—coronary artery disease	6.45e-05	0.000552	CcSEcCtD
Rifabutin—Asthenia—Losartan—coronary artery disease	6.45e-05	0.000552	CcSEcCtD
Rifabutin—Headache—Enalapril—coronary artery disease	6.45e-05	0.000551	CcSEcCtD
Rifabutin—Pain—Timolol—coronary artery disease	6.44e-05	0.000551	CcSEcCtD
Rifabutin—Nausea—Niacin—coronary artery disease	6.42e-05	0.000549	CcSEcCtD
Rifabutin—Rash—Telmisartan—coronary artery disease	6.4e-05	0.000547	CcSEcCtD
Rifabutin—Dermatitis—Telmisartan—coronary artery disease	6.39e-05	0.000547	CcSEcCtD
Rifabutin—Diarrhoea—Furosemide—coronary artery disease	6.37e-05	0.000545	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.37e-05	0.000545	CcSEcCtD
Rifabutin—Pruritus—Losartan—coronary artery disease	6.36e-05	0.000544	CcSEcCtD
Rifabutin—Headache—Telmisartan—coronary artery disease	6.36e-05	0.000544	CcSEcCtD
Rifabutin—Feeling abnormal—Ramipril—coronary artery disease	6.35e-05	0.000543	CcSEcCtD
Rifabutin—Insomnia—Lisinopril—coronary artery disease	6.32e-05	0.000541	CcSEcCtD
Rifabutin—Nausea—Pravastatin—coronary artery disease	6.32e-05	0.00054	CcSEcCtD
Rifabutin—Gastrointestinal pain—Ramipril—coronary artery disease	6.3e-05	0.000539	CcSEcCtD
Rifabutin—Paraesthesia—Lisinopril—coronary artery disease	6.28e-05	0.000537	CcSEcCtD
Rifabutin—Vomiting—Captopril—coronary artery disease	6.28e-05	0.000537	CcSEcCtD
Rifabutin—Dyspnoea—Lisinopril—coronary artery disease	6.23e-05	0.000533	CcSEcCtD
Rifabutin—Rash—Captopril—coronary artery disease	6.22e-05	0.000532	CcSEcCtD
Rifabutin—Dermatitis—Captopril—coronary artery disease	6.22e-05	0.000532	CcSEcCtD
Rifabutin—Feeling abnormal—Timolol—coronary artery disease	6.21e-05	0.000531	CcSEcCtD
Rifabutin—Headache—Captopril—coronary artery disease	6.18e-05	0.000529	CcSEcCtD
Rifabutin—Gastrointestinal pain—Timolol—coronary artery disease	6.16e-05	0.000527	CcSEcCtD
Rifabutin—Dyspepsia—Lisinopril—coronary artery disease	6.15e-05	0.000526	CcSEcCtD
Rifabutin—Diarrhoea—Losartan—coronary artery disease	6.15e-05	0.000526	CcSEcCtD
Rifabutin—Nausea—Trandolapril—coronary artery disease	6.14e-05	0.000525	CcSEcCtD
Rifabutin—Nausea—Enalapril—coronary artery disease	6.11e-05	0.000523	CcSEcCtD
Rifabutin—Vomiting—Perindopril—coronary artery disease	6.09e-05	0.000521	CcSEcCtD
Rifabutin—Abdominal pain—Ramipril—coronary artery disease	6.09e-05	0.000521	CcSEcCtD
Rifabutin—Body temperature increased—Ramipril—coronary artery disease	6.09e-05	0.000521	CcSEcCtD
Rifabutin—Decreased appetite—Lisinopril—coronary artery disease	6.08e-05	0.00052	CcSEcCtD
Rifabutin—Rash—Perindopril—coronary artery disease	6.04e-05	0.000517	CcSEcCtD
Rifabutin—Dermatitis—Perindopril—coronary artery disease	6.04e-05	0.000516	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.03e-05	0.000516	CcSEcCtD
Rifabutin—Nausea—Telmisartan—coronary artery disease	6.03e-05	0.000516	CcSEcCtD
Rifabutin—Headache—Perindopril—coronary artery disease	6e-05	0.000513	CcSEcCtD
Rifabutin—Pain—Lisinopril—coronary artery disease	5.98e-05	0.000511	CcSEcCtD
Rifabutin—Abdominal pain—Timolol—coronary artery disease	5.96e-05	0.000509	CcSEcCtD
Rifabutin—Body temperature increased—Timolol—coronary artery disease	5.96e-05	0.000509	CcSEcCtD
Rifabutin—Vomiting—Furosemide—coronary artery disease	5.92e-05	0.000507	CcSEcCtD
Rifabutin—Rash—Furosemide—coronary artery disease	5.87e-05	0.000502	CcSEcCtD
Rifabutin—Dermatitis—Furosemide—coronary artery disease	5.87e-05	0.000502	CcSEcCtD
Rifabutin—Nausea—Captopril—coronary artery disease	5.86e-05	0.000501	CcSEcCtD
Rifabutin—Headache—Furosemide—coronary artery disease	5.84e-05	0.000499	CcSEcCtD
Rifabutin—Feeling abnormal—Lisinopril—coronary artery disease	5.76e-05	0.000493	CcSEcCtD
Rifabutin—Gastrointestinal pain—Lisinopril—coronary artery disease	5.72e-05	0.000489	CcSEcCtD
Rifabutin—Vomiting—Losartan—coronary artery disease	5.71e-05	0.000489	CcSEcCtD
Rifabutin—Nausea—Perindopril—coronary artery disease	5.69e-05	0.000487	CcSEcCtD
Rifabutin—Hypersensitivity—Ramipril—coronary artery disease	5.68e-05	0.000486	CcSEcCtD
Rifabutin—Rash—Losartan—coronary artery disease	5.67e-05	0.000485	CcSEcCtD
Rifabutin—Dermatitis—Losartan—coronary artery disease	5.66e-05	0.000484	CcSEcCtD
Rifabutin—Headache—Losartan—coronary artery disease	5.63e-05	0.000482	CcSEcCtD
Rifabutin—Hypersensitivity—Timolol—coronary artery disease	5.55e-05	0.000475	CcSEcCtD
Rifabutin—Nausea—Furosemide—coronary artery disease	5.53e-05	0.000473	CcSEcCtD
Rifabutin—Asthenia—Ramipril—coronary artery disease	5.53e-05	0.000473	CcSEcCtD
Rifabutin—Body temperature increased—Lisinopril—coronary artery disease	5.53e-05	0.000473	CcSEcCtD
Rifabutin—Abdominal pain—Lisinopril—coronary artery disease	5.53e-05	0.000473	CcSEcCtD
Rifabutin—Pruritus—Ramipril—coronary artery disease	5.45e-05	0.000466	CcSEcCtD
Rifabutin—Asthenia—Timolol—coronary artery disease	5.41e-05	0.000462	CcSEcCtD
Rifabutin—Nausea—Losartan—coronary artery disease	5.34e-05	0.000457	CcSEcCtD
Rifabutin—Pruritus—Timolol—coronary artery disease	5.33e-05	0.000456	CcSEcCtD
Rifabutin—Diarrhoea—Ramipril—coronary artery disease	5.27e-05	0.000451	CcSEcCtD
Rifabutin—Diarrhoea—Timolol—coronary artery disease	5.15e-05	0.000441	CcSEcCtD
Rifabutin—Hypersensitivity—Lisinopril—coronary artery disease	5.15e-05	0.00044	CcSEcCtD
Rifabutin—Asthenia—Lisinopril—coronary artery disease	5.01e-05	0.000429	CcSEcCtD
Rifabutin—Pruritus—Lisinopril—coronary artery disease	4.94e-05	0.000423	CcSEcCtD
Rifabutin—Vomiting—Ramipril—coronary artery disease	4.9e-05	0.000419	CcSEcCtD
Rifabutin—Rash—Ramipril—coronary artery disease	4.86e-05	0.000416	CcSEcCtD
Rifabutin—Dermatitis—Ramipril—coronary artery disease	4.85e-05	0.000415	CcSEcCtD
Rifabutin—Headache—Ramipril—coronary artery disease	4.83e-05	0.000413	CcSEcCtD
Rifabutin—Vomiting—Timolol—coronary artery disease	4.79e-05	0.00041	CcSEcCtD
Rifabutin—Diarrhoea—Lisinopril—coronary artery disease	4.78e-05	0.000409	CcSEcCtD
Rifabutin—Rash—Timolol—coronary artery disease	4.75e-05	0.000406	CcSEcCtD
Rifabutin—Dermatitis—Timolol—coronary artery disease	4.75e-05	0.000406	CcSEcCtD
Rifabutin—Headache—Timolol—coronary artery disease	4.72e-05	0.000404	CcSEcCtD
Rifabutin—Nausea—Ramipril—coronary artery disease	4.58e-05	0.000392	CcSEcCtD
Rifabutin—Nausea—Timolol—coronary artery disease	4.48e-05	0.000383	CcSEcCtD
Rifabutin—Vomiting—Lisinopril—coronary artery disease	4.44e-05	0.00038	CcSEcCtD
Rifabutin—Rash—Lisinopril—coronary artery disease	4.41e-05	0.000377	CcSEcCtD
Rifabutin—Dermatitis—Lisinopril—coronary artery disease	4.4e-05	0.000377	CcSEcCtD
Rifabutin—Headache—Lisinopril—coronary artery disease	4.38e-05	0.000374	CcSEcCtD
Rifabutin—Nausea—Lisinopril—coronary artery disease	4.15e-05	0.000355	CcSEcCtD
Rifabutin—CYP1A2—Metabolism—PLCD1—coronary artery disease	6.2e-06	5.94e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—POMC—coronary artery disease	6.17e-06	5.91e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—coronary artery disease	6.15e-06	5.89e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AGT—coronary artery disease	6.13e-06	5.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—LEP—coronary artery disease	6e-06	5.75e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOE—coronary artery disease	6e-06	5.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PGM1—coronary artery disease	5.97e-06	5.72e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—IL6—coronary artery disease	5.95e-06	5.7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APOA1—coronary artery disease	5.93e-06	5.68e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL1B—coronary artery disease	5.92e-06	5.67e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—coronary artery disease	5.88e-06	5.63e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—coronary artery disease	5.87e-06	5.63e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	5.87e-06	5.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SULT4A1—coronary artery disease	5.87e-06	5.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PDK4—coronary artery disease	5.87e-06	5.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PYGM—coronary artery disease	5.87e-06	5.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CKMT2—coronary artery disease	5.87e-06	5.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—POMC—coronary artery disease	5.85e-06	5.61e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK14—coronary artery disease	5.84e-06	5.6e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	5.84e-06	5.59e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	5.78e-06	5.54e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PYGB—coronary artery disease	5.77e-06	5.52e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CKB—coronary artery disease	5.77e-06	5.52e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ESR1—coronary artery disease	5.73e-06	5.49e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—F2—coronary artery disease	5.66e-06	5.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FN1—coronary artery disease	5.66e-06	5.42e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6ST—coronary artery disease	5.64e-06	5.4e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ALB—coronary artery disease	5.62e-06	5.39e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NFKBIA—coronary artery disease	5.59e-06	5.36e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—AKT1—coronary artery disease	5.49e-06	5.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLIN1—coronary artery disease	5.42e-06	5.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—COX5B—coronary artery disease	5.42e-06	5.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DLAT—coronary artery disease	5.42e-06	5.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM2—coronary artery disease	5.42e-06	5.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PFKFB3—coronary artery disease	5.42e-06	5.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KIT—coronary artery disease	5.42e-06	5.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—NOS3—coronary artery disease	5.38e-06	5.15e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LDHA—coronary artery disease	5.23e-06	5.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GK—coronary artery disease	5.23e-06	5.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PFKM—coronary artery disease	5.23e-06	5.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GYG1—coronary artery disease	5.23e-06	5.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMGCS2—coronary artery disease	5.23e-06	5.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GATM—coronary artery disease	5.23e-06	5.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GSK3B—coronary artery disease	5.2e-06	4.98e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—POMC—coronary artery disease	5.16e-06	4.94e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CREB1—coronary artery disease	5.16e-06	4.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	5.16e-06	4.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SULT1E1—coronary artery disease	5.14e-06	4.92e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCL2—coronary artery disease	5.05e-06	4.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6R—coronary artery disease	5.03e-06	4.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCH1—coronary artery disease	4.99e-06	4.78e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AK1—coronary artery disease	4.99e-06	4.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	4.99e-06	4.78e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1—coronary artery disease	4.96e-06	4.75e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—coronary artery disease	4.92e-06	4.71e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKR1B1—coronary artery disease	4.9e-06	4.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HK2—coronary artery disease	4.9e-06	4.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—UGCG—coronary artery disease	4.79e-06	4.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPAT—coronary artery disease	4.79e-06	4.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MDH2—coronary artery disease	4.79e-06	4.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCD1—coronary artery disease	4.79e-06	4.59e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—SERPINE1—coronary artery disease	4.71e-06	4.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC27A1—coronary artery disease	4.7e-06	4.5e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CPT1B—coronary artery disease	4.61e-06	4.42e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LCAT—coronary artery disease	4.61e-06	4.42e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PGM1—coronary artery disease	4.61e-06	4.41e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FGF2—coronary artery disease	4.56e-06	4.37e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA4—coronary artery disease	4.53e-06	4.33e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—coronary artery disease	4.51e-06	4.32e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—NOS3—coronary artery disease	4.5e-06	4.31e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PYGB—coronary artery disease	4.45e-06	4.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CKB—coronary artery disease	4.45e-06	4.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	4.44e-06	4.26e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JAK2—coronary artery disease	4.37e-06	4.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PDHA1—coronary artery disease	4.37e-06	4.19e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCLM—coronary artery disease	4.37e-06	4.19e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TGFB1—coronary artery disease	4.25e-06	4.07e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	4.24e-06	4.06e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP11B2—coronary artery disease	4.23e-06	4.05e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—TXNRD1—coronary artery disease	4.23e-06	4.05e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PFKFB3—coronary artery disease	4.18e-06	4.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM2—coronary artery disease	4.18e-06	4.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLIN1—coronary artery disease	4.18e-06	4.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DLAT—coronary artery disease	4.18e-06	4.01e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—COX5B—coronary artery disease	4.18e-06	4.01e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC22A3—coronary artery disease	4.17e-06	3.99e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—coronary artery disease	4.16e-06	3.99e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ARNTL—coronary artery disease	4.11e-06	3.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HADH—coronary artery disease	4.11e-06	3.94e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	4.05e-06	3.87e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CXCL8—coronary artery disease	3.99e-06	3.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SULT1E1—coronary artery disease	3.97e-06	3.8e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	3.95e-06	3.78e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—coronary artery disease	3.91e-06	3.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA2—coronary artery disease	3.9e-06	3.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX2—coronary artery disease	3.9e-06	3.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	3.9e-06	3.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX4—coronary artery disease	3.85e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SULT1A1—coronary artery disease	3.85e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCG5—coronary artery disease	3.85e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HK1—coronary artery disease	3.85e-06	3.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	3.84e-06	3.68e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP3—coronary artery disease	3.82e-06	3.66e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HADHA—coronary artery disease	3.8e-06	3.64e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKR1B1—coronary artery disease	3.78e-06	3.62e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HK2—coronary artery disease	3.78e-06	3.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTA1—coronary artery disease	3.76e-06	3.6e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—coronary artery disease	3.72e-06	3.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LPA—coronary artery disease	3.72e-06	3.56e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC27A1—coronary artery disease	3.63e-06	3.47e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—coronary artery disease	3.61e-06	3.46e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MMP9—coronary artery disease	3.61e-06	3.46e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLCB3—coronary artery disease	3.6e-06	3.45e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA5—coronary artery disease	3.56e-06	3.41e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CPT1B—coronary artery disease	3.56e-06	3.41e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LCAT—coronary artery disease	3.56e-06	3.41e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—P4HB—coronary artery disease	3.49e-06	3.35e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA4—coronary artery disease	3.49e-06	3.34e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL6—coronary artery disease	3.47e-06	3.32e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	3.46e-06	3.31e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	3.43e-06	3.28e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.39e-06	3.25e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.37e-06	3.23e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCLM—coronary artery disease	3.37e-06	3.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.35e-06	3.21e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.27e-06	3.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.27e-06	3.13e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—coronary artery disease	3.24e-06	3.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—VCAN—coronary artery disease	3.23e-06	3.1e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.22e-06	3.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDOA—coronary artery disease	3.21e-06	3.07e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—IL6—coronary artery disease	3.2e-06	3.06e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—AKT1—coronary artery disease	3.2e-06	3.06e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.17e-06	3.04e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HADH—coronary artery disease	3.17e-06	3.04e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—DCN—coronary artery disease	3.11e-06	2.98e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH2—coronary artery disease	3.03e-06	2.9e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—coronary artery disease	3.03e-06	2.9e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX2—coronary artery disease	3.01e-06	2.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.01e-06	2.88e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA2—coronary artery disease	3.01e-06	2.88e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TGFB1—coronary artery disease	2.97e-06	2.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX4—coronary artery disease	2.97e-06	2.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	2.97e-06	2.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HK1—coronary artery disease	2.97e-06	2.84e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCG5—coronary artery disease	2.97e-06	2.84e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.95e-06	2.83e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—AKT1—coronary artery disease	2.95e-06	2.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LIPC—coronary artery disease	2.95e-06	2.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HBA1—coronary artery disease	2.95e-06	2.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.95e-06	2.83e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.95e-06	2.83e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HADHA—coronary artery disease	2.93e-06	2.81e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOC3—coronary artery disease	2.93e-06	2.81e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—coronary artery disease	2.92e-06	2.79e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LDLR—coronary artery disease	2.92e-06	2.79e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.91e-06	2.79e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTA1—coronary artery disease	2.9e-06	2.78e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.88e-06	2.76e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.88e-06	2.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LPA—coronary artery disease	2.87e-06	2.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CETP—coronary artery disease	2.85e-06	2.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GCLC—coronary artery disease	2.85e-06	2.73e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SDC1—coronary artery disease	2.82e-06	2.7e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCB3—coronary artery disease	2.78e-06	2.66e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA5—coronary artery disease	2.75e-06	2.63e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—P4HB—coronary artery disease	2.7e-06	2.58e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.66e-06	2.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.66e-06	2.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.66e-06	2.54e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	2.65e-06	2.53e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CTGF—coronary artery disease	2.6e-06	2.49e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.58e-06	2.47e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GOT2—coronary artery disease	2.58e-06	2.47e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—coronary artery disease	2.53e-06	2.42e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—VCAN—coronary artery disease	2.5e-06	2.39e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.48e-06	2.37e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—AKT1—coronary artery disease	2.47e-06	2.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—DCN—coronary artery disease	2.4e-06	2.3e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.37e-06	2.27e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.34e-06	2.24e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.32e-06	2.23e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.3e-06	2.2e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HBA1—coronary artery disease	2.28e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LIPC—coronary artery disease	2.28e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.28e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.28e-06	2.18e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOC3—coronary artery disease	2.26e-06	2.17e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LDLR—coronary artery disease	2.25e-06	2.16e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL6—coronary artery disease	2.24e-06	2.15e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.22e-06	2.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.22e-06	2.13e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GOT1—coronary artery disease	2.22e-06	2.13e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GGT1—coronary artery disease	2.22e-06	2.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GCLC—coronary artery disease	2.2e-06	2.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CETP—coronary artery disease	2.2e-06	2.11e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SDC1—coronary artery disease	2.17e-06	2.08e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKT1—coronary artery disease	2.07e-06	1.98e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.05e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.05e-06	1.97e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CTGF—coronary artery disease	2.01e-06	1.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—coronary artery disease	2e-06	1.91e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GOT2—coronary artery disease	1.99e-06	1.9e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.99e-06	1.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.98e-06	1.9e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.97e-06	1.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CAT—coronary artery disease	1.94e-06	1.86e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOB—coronary artery disease	1.89e-06	1.81e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.84e-06	1.76e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.83e-06	1.75e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LPL—coronary artery disease	1.8e-06	1.73e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.77e-06	1.7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPX1—coronary artery disease	1.76e-06	1.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GGT1—coronary artery disease	1.72e-06	1.64e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GOT1—coronary artery disease	1.72e-06	1.64e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CD36—coronary artery disease	1.71e-06	1.64e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.69e-06	1.62e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.62e-06	1.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.54e-06	1.48e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AGT—coronary artery disease	1.54e-06	1.48e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.53e-06	1.46e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.52e-06	1.46e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOE—coronary artery disease	1.51e-06	1.45e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CAT—coronary artery disease	1.5e-06	1.44e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APOA1—coronary artery disease	1.49e-06	1.43e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOB—coronary artery disease	1.46e-06	1.39e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.43e-06	1.37e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.42e-06	1.36e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LPL—coronary artery disease	1.39e-06	1.33e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPX1—coronary artery disease	1.36e-06	1.3e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CD36—coronary artery disease	1.32e-06	1.27e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPARG—coronary artery disease	1.32e-06	1.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.3e-06	1.25e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—POMC—coronary artery disease	1.3e-06	1.24e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.25e-06	1.2e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AGT—coronary artery disease	1.19e-06	1.14e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALB—coronary artery disease	1.18e-06	1.13e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOE—coronary artery disease	1.17e-06	1.12e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APOA1—coronary artery disease	1.15e-06	1.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—NOS3—coronary artery disease	1.13e-06	1.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.03e-06	9.91e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPARG—coronary artery disease	1.02e-06	9.72e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—POMC—coronary artery disease	1e-06	9.59e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALB—coronary artery disease	9.13e-07	8.74e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—NOS3—coronary artery disease	8.73e-07	8.36e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—coronary artery disease	7.99e-07	7.65e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—coronary artery disease	6.37e-07	6.1e-06	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—AKT1—coronary artery disease	5.2e-07	4.98e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	4.91e-07	4.71e-06	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—AKT1—coronary artery disease	4.01e-07	3.84e-06	CbGpPWpGaD
